8-K - AbbVie Inc. (0001551152) (Filer)
AbbVie Inc.（CIK 0001551152）于2026-10-30向SEC提交8-K，报告期为2026-10-30，共14份文件，涉及Item 2.02经营业绩与财务状况、Item 9.01财务报表与附件。文件未在正文中列出具体业绩数字。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-30
Accepted
2026-10-30 07:51:51
Documents
14
Period of Report
2026-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)
EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 261504453
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov